Recent advances in the development of human rhinovirus 3C protease inhibitors

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 2, 2001, Pages 177-184

  Dragovich, P S ^a  

^a AGOURON PHARMACEUTICALS INC   (United States)

Author keywords

3C protease; Antirhinoviral agents; Human rhinovirus; Protease inhibitors

Indexed keywords

ALDEHYDE DERIVATIVE; ANTIVIRUS AGENT; CARBOXYLIC ACID DERIVATIVE; CELL ENZYME; CYSTEINE; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDE DERIVATIVE; ENZYME INHIBITOR; ESTER DERIVATIVE; GLUTAMINE; GLYCINE; ISOPROTEIN; LACTAM DERIVATIVE; LEUCINE; METHIONINE SULFONE; NEW DRUG; PHENYLALANINE; POLYPEPTIDE; PROTEINASE; PROTEINASE INHIBITOR; RNA BINDING PROTEIN; SYNTHETIC PEPTIDE; THIOCARBAMIC ACID DERIVATIVE; TRIPEPTIDE DERIVATIVE; UNINDEXED DRUG; VINYL DERIVATIVE; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; COMMON COLD; CONTROLLED STUDY; DRUG DESIGN; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN RHINOVIRUS; NONHUMAN; PATENT; PROTEINASE INHIBITION; REVIEW; STRAIN DIFFERENCE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0035146966     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.2.177     Document Type: Review

References (48)

1. Rhinoviruses
2. Picornaviridae: The viruses and their replication
3. A collaborative report: Rhinoviruses-extension of the numbering system from 89 to 100
4. Proteolytic enzymes of the viruses of the family picornaviridae
5. The 3C proteinases of picornaviruses and other positive-sense, single-stranded RNA viruses
6. Poliovirus proteinase 3C converts an active form of transcription Factor IIIC to an inactive form: A mechanism for inhibition of host cell polymerase III transcription by poliovirus
7. The expression and purification of human rhinovirus protease 3C
8. Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli
9. Efficient expression and purification of a protease from the common cold virus, human rhinovirus Type 14
10. Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli
11. Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli
12. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides
13. Design, synthesis and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease
14. Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli
15. A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase
16. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro
17. Site-directed mutagenesis suggests close functional relationship between human rhinovirus 3C protease and cellular trypsin-like serine protease
18. Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5′-noncoding region of the viral RNA
19. Identification and characterization of human rhinovirus-14 3C protease deamidation isoform
20. Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase
21. Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay
22. Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases
23. A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates
24. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA binding site and means for cleaving precursor polyprotein
25. Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group
26. Poliovirus-encoded proteinase 3C: A possible evolutionary link between cellular serine and cysteine proteinase families
27. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
28. Human rhinovirus 3C protease inhibitors: Recent developments
29. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections
30. Design of rhinovirus protease inhibitors for the treatment of the common cold
31. Vinylogous amino acid esters: A new class of inactivators for thiol proteases
32. Vinyl sulfones as mechanism-based cysteine protease inhibitors
33. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication
34. Structure-based design, synthesis and biological evaluation of irreversible human rhinovirus 3C protease inhibitors 1. Michael-acceptor structure-activity studies
35. Structure-based design, synthesis and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies
36. Solidphase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides
37. Structure-based design, synthesis and biological evaluation of irreversible human rhinovirus 3C protease inhibitors 3. Structure-activity studies of ketomethylene-containing peptidomimetics
38. Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids
39. 1 lactam moieties as L-glutamine replacements
40. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease
41. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor
42. AG-7088, anti-rhinovirus drug HRV 3C protease inhibitor
43. Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis and biological evaluation
44. Azodicarboxamides: A new class of cysteine protease inhibitor for hepatitis A virus and human rhinovirus 3C enzymes
45. Design, synthesis and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease
46. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
47. Pleconaril, a broad spectrum antipicornaviral agent
48. S-Nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease